Hypoxia-inducible factor 1 alpha represses the transcription of the estrogen receptor alpha gene in human breast cancer cells.

The estrogen receptor is one of the most important transcription factors in breast tumor growth and development. We, and others, have previously shown that hypoxia induces rapid ERα protein degradation by a proteasome-mediated pathway in breast cancer cells, which is linked with ERα activation. However, no report has shown the effect of hypoxia on ESR1 gene regulation at the transcriptional level. In this report, we show that hypoxia repressed the expression of ERα mRNA in MCF-7 and T47D human breast cancer cells, but not in human endometrial Ishikawa cells, although ERα degradation under hypoxia was also observed in Ishikawa cells. This indicates that ESR1 transcriptional repression and ERα protein downregulation by hypoxia are regulated by distinct mechanisms. Repression of ESR1 gene transcription occurred at the transcriptional level as a result of decreased recruitment of RNA polymerase II at the proximal promoter of the ESR1 locus in response to stabilization of the HIF-1α protein under hypoxia. Our data show that hypoxia induces repression of the ESR1 gene, which may facilitate hormone insensitivity in the tumor microenvironment.

[1]  R. Hill,et al.  Hypoxia and Metastasis , 2007, Clinical Cancer Research.

[2]  Victor X Jin,et al.  Loss of Estrogen Receptor Signaling Triggers Epigenetic Silencing of Downstream Targets in Breast Cancer , 2004, Cancer Research.

[3]  Adrian V. Lee,et al.  Proteasome inhibition represses ERα gene expression in ER+ cells- a new link between proteasome activity and estrogen signaling in breast cancer , 2009, Oncogene.

[4]  D. Coradini,et al.  Hypoxia and estrogen receptor profile influence the responsiveness of human breast cancer cells to estradiol and antiestrogens , 2003, Cellular and Molecular Life Sciences CMLS.

[5]  J. Simons,et al.  Hypoxia-inducible factor-1 in human breast and prostate cancer. , 2006, Endocrine-related cancer.

[6]  S. Ellison-Zelski,et al.  Repression of ESR1 through Actions of Estrogen Receptor Alpha and Sin3A at the Proximal Promoter , 2009, Molecular and Cellular Biology.

[7]  Jiannis Ragoussis,et al.  Genome-wide Association of Hypoxia-inducible Factor (HIF)-1α and HIF-2α DNA Binding with Expression Profiling of Hypoxia-inducible Transcripts , 2009, The Journal of Biological Chemistry.

[8]  Youngjoo Lee,et al.  Cobalt Chloride-Induced Estrogen Receptor α Down-Regulation Involves Hypoxia-Inducible Factor-1α in MCF-7 Human Breast Cancer Cells , 2005 .

[9]  Emmanuel Chamorey,et al.  HIF‐1α and CA IX staining in invasive breast carcinomas: Prognosis and treatment outcome , 2007 .

[10]  J. Pouysségur,et al.  Oxygen, a source of life and stress , 2007, FEBS letters.

[11]  R. Schiff,et al.  Resistance to endocrine therapy in breast cancer: exploiting estrogen receptor/growth factor signaling crosstalk. , 2006, Endocrine-related cancer.

[12]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[13]  Youngjoo Lee,et al.  Cobalt chloride-induced estrogen receptor alpha down-regulation involves hypoxia-inducible factor-1alpha in MCF-7 human breast cancer cells. , 2005, Molecular endocrinology.

[14]  Nan Li,et al.  Human Phosphatidylethanolamine-binding Protein 4 Promotes Transactivation of Estrogen Receptor α (ERα) in Human Cancer Cells by Inhibiting Proteasome-dependent ERα Degradation via Association with Src* , 2010, The Journal of Biological Chemistry.

[15]  P. V. van Diest,et al.  Expression of hypoxia-inducible factor-1α and cell cycle proteins in invasive breast cancer are estrogen receptor related , 2004, Breast Cancer Research.

[16]  S. Safe,et al.  Hypoxia induces proteasome-dependent degradation of estrogen receptor alpha in ZR-75 breast cancer cells. , 2002, Molecular endocrinology.

[17]  Yusuke Nakamura,et al.  Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells. , 2009, Cancer research.

[18]  M. Shupnik,et al.  ERβ in breast cancer—Onlooker, passive player, or active protector? , 2008, Steroids.

[19]  E. Alarid,et al.  Amping up estrogen receptors in breast cancer , 2007, Breast Cancer Research.

[20]  Diego Villar,et al.  Genome-wide identification of hypoxia-inducible factor binding sites and target genes by a probabilistic model integrating transcription-profiling data and in silico binding site prediction , 2010, Nucleic acids research.

[21]  Emmanuel Chamorey,et al.  HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome. , 2007, International journal of cancer.

[22]  Jiannis Ragoussis,et al.  Concordant Regulation of Gene Expression by Hypoxia and 2-Oxoglutarate-dependent Dioxygenase Inhibition , 2006, Journal of Biological Chemistry.

[23]  Naz Chaudary,et al.  Hypoxia and metastasis in breast cancer. , 2006, Breast disease.

[24]  H. Iwase,et al.  Hypoxia-inducible factor 1α is closely linked to an aggressive phenotype in breast cancer , 2008, Breast Cancer Research and Treatment.

[25]  L. Murphy,et al.  Estrogen receptor alpha negative breast cancer patients: Estrogen receptor beta as a therapeutic target , 2008, The Journal of Steroid Biochemistry and Molecular Biology.

[26]  J. Pouysségur,et al.  Hypoxia and cancer , 2007, Journal of Molecular Medicine.

[27]  N. Colburn,et al.  Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion , 2010, Oncogene.